Kaleido Biosciences, Inc.
KLDO
Revenue
492.00k
▲388.00k▲373.08%
3 Months ChangeAssets
50.14M
▼-17.67M▼-26.06%
3 Months ChangeLiabilities
39.53M
▲926.00k▲2.40%
3 Months ChangeFree Cash Flow
-24.00M
▼-5.03M▼-26.51%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2022-04-08
Form 8-K
ID: 0001193125-22-099802
2022-03-17
Form 8-K
ID: 0000950170-22-004108
2022-03-09
Form 8-K
ID: 0000950170-22-003232
2022-01-28
Form 8-K
ID: 0000950170-22-000560
2021-11-01
Form 10-Q
ID: 0000950170-21-002534
2021-11-01
Form 8-K
ID: 0000950170-21-002533
2021-10-05
Form 8-K
ID: 0001564590-21-050100
2021-09-03
Form 8-K
ID: 0001564590-21-047100
2021-08-11
Form 10-Q
ID: 0001564590-21-043227
2021-08-11
Form 8-K
ID: 0001564590-21-043224